CTI BioPharma OverviewCTI BioPharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CTIC.
Quarterly EBIT
-$9.23M
↑ 73.7% YoY
As of Mar 31, 2023
Annual EBIT (TTM)
-$53.93M
↑ 52.43% YoY
Trailing 12 months ending Mar 31, 2023
CTI BioPharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for CTIC.
As of Mar 31, 2023
Trailing 12 months ending Mar 31, 2023